Prostate cancer Trials in Copenhagen, Denmark
Conditions / Prostate cancer / Copenhagen, Denmark
Prostate cancer is a medical condition with active clinical research programs worldwide.
39 total trials for this combination
Showing top 10 of 39 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02960022 | A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study | RECRUITING | PHASE2 |
| NCT00554229 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases | COMPLETED | PHASE3 |
| NCT02437539 | Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | COMPLETED | PHASE1 |
| NCT02139371 | Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | COMPLETED | EARLY_PHASE1 |
| NCT01212991 | A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer | COMPLETED | PHASE3 |
| NCT03511664 | Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT02003924 | Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT02319837 | Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00988208 | Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer | TERMINATED | PHASE3 |